[Disorders of leukopoiesis after oral treatment of diabetes].
D000284:Administration, Oral; D000380:Agranulocytosis / Q000209:etiology*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D019891:Leukopoiesis
D007004:Hypoglycemic Agents
AGRANULOCYTOSIS/etiology and pathogenesis; ANTIDIABETICS/injurious effects
Störungen der Leukopoese nach oraler Diabetesbehandlung.